Cardiovascular research is rapidly advancing from fundamental discoveries toward translational and clinical applications. CardioFrontiers 2026 will bring together leading scientists, emerging investigators, and research professionals to exchange new findings and explore the latest advances in cardiovascular science.
Taking place September 11–14, 2026, at the Texas Medical Center in Houston, Texas, the conference will focus on key areas including cardiac development, cardiovascular disease, and cardiac regeneration, bridging fundamental biology with translational and clinical research.
To support researchers investigating the molecular mechanisms of cardiovascular health and disease, Yeasen Biotechnology Co., Ltd. will participate in CardioFrontiers 2026 and connect with the cardiovascular research community. Our team looks forward to discussing how reliable molecular biology technologies and high-performance reagents can support experimental efficiency, reproducibility, and data quality across cardiovascular research workflows.
📅 Event Information
We look forward to meeting researchers in Houston and exchanging ideas about the technologies enabling the next generation of cardiovascular discovery.
- Event: CardioFrontiers 2026 – Pioneering Advances in Cardiovascular Science
- Date: September 11–14, 2026
- Location: Texas Medical Center, Houston, Texas, USA
- September 11 & 14: McGovern Medical School at UTHealth Houston
- September 12 & 13: Baylor College of Medicine
Featured Products
|
Category |
Cat. No. |
Product |
Key Features |
|
DNA/RNA Transfection |
Hieff Trans™ Booster DNA/RNA Transfection Reagent |
· High transfection efficiency · Low cytotoxicity · Supports DNA, siRNA, miRNA, mRNA and ASO · Suitable for primary and hard-to-transfect cells |
|
|
siRNA Transfection |
Hieff Trans™ RNAiBoost Transfection Reagent |
· Efficient siRNA delivery · Strong gene knockdown performance · Rapid complex formation · No medium change required |
|
|
Macrophage Depletion |
Clodronate Liposomes Kit (With Control Liposomes) |
· Effective macrophage depletion · Includes control liposomes · Suitable for in vivo studies · Supports inflammation and immune-related research |
|
|
Reverse Transcription |
Hifair™ AdvanceFast 1st Strand cDNA Synthesis SuperMix for qPCR (gDNA digester plus) |
· 5-min reverse transcription · High sensitivity · Efficient gDNA removal · High inhibitor tolerance |
|
|
Hifair™ ColorGPS All-in-One RT-gDNA Digestion SuperMix for qPCR |
· One-tube gDNA removal and reverse transcription · 15-min workflow · Visual tracking dye · Streamlined operation |
||
|
SYBR qPCR |
Hieff UNICON™ Universal Blue qPCR Master Mix (SYBR) |
· Blue visual indicator · Antibody-mediated hot-start Taq · High specificity · Broad instrument compatibility |
🎯 Why Connect with Yeasen at CardioFrontiers 2026?
CardioFrontiers 2026 provides an important platform for researchers to exchange discoveries across cardiac development, cardiovascular disease, regeneration, and translational cardiovascular science.
Yeasen Biotechnology looks forward to connecting with the cardiovascular research community in Houston and supporting researchers with reliable molecular tools for advancing cardiovascular discovery.
🌐 Additional Information
- Official Conference: CardioFrontiers 2026
- Conference Dates: September 11–14, 2026
- Conference Website: https://www.jfmartinlab.com/cardiofrontiers
- Yeasen Website: https://www.yeasenbio.com/
- Email: info@yeasenbio.com
